Anavex Life Sciences Provides an Update on Rett Syndrome Program
Go back to Anavex Life Sciences Provides an Update on Rett Syndrome Program| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 2.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.71 | 52 Week High | $8.30 | |||
| Open | $2.71 | 52 Week Low | $2.43 | |||
| Day High | $2.71 | P/E | N/A | |||
| Day Low | $2.71 | EPS | $-0.22 | |||
| Volume | 181 | |||||
| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 2.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.71 | 52 Week High | $8.30 | |||
| Open | $2.71 | 52 Week Low | $2.43 | |||
| Day High | $2.71 | P/E | N/A | |||
| Day Low | $2.71 | EPS | $-0.22 | |||
| Volume | 181 | |||||

